Correcting QT for Heart Rate When Both are Affected by a Drug Georg Ferber Commentary 12 November 2018 Pages: 335 - 337
Pharmacovigilance in India: Present Scenario and Future Challenges V. KalaiselvanSushma SrivastavaSK Gupta Leading Article 29 September 2018 Pages: 339 - 346
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? Gianluca TrifiròRosa GiniGiovanni Corrao Review Article 29 September 2018 Pages: 347 - 363
Drug-Induced Liver Injury: Highlights of the Recent Literature Mark RealMichele S. BarnhillJames H. Lewis Review Article 20 October 2018 Pages: 365 - 387
Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy Su GolderStephanie ChiuveGraciela Gonzalez-Hernandez Original Research Article Open access 03 October 2018 Pages: 389 - 400
Implications of Individual QT/RR Profiles—Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections Marek MalikChristine GarnettNorman Stockbridge Original Research Article Open access 25 September 2018 Pages: 401 - 414
Implications of Individual QT/RR Profiles—Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc Changes Marek MalikChristine GarnettNorman Stockbridge Original Research Article Open access 25 September 2018 Pages: 415 - 426
Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis Irma ConvertinoStefano SalvadoriMarco Tuccori Original Research Article 01 October 2018 Pages: 427 - 444
Preventing Future Deaths from Medicines: Responses to Coroners’ Concerns in England and Wales Robin E. FernerTohfa AhmadAnthony R. Cox Original Research Article 08 October 2018 Pages: 445 - 451
Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development Nadezda AbramovaJulie HubbardEmilia Richter Original Research Article Open access 19 October 2018 Pages: 453 - 461
Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017 Birgit EhlkenLennart NathellStefan Wohlfeil Original Research Article Open access 10 December 2018 Pages: 463 - 471
Correction to: Implications of Individual QT/RR Profiles—Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections Marek MalikChristine GarnettNorman Stockbridge Correction Open access 09 March 2019 Pages: 473 - 473
Correction to: Implications of Individual QT/RR Profiles—Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc Changes Marek MalikChristine GarnettNorman Stockbridge Correction Open access 06 February 2019 Pages: 475 - 475